Directory Neurotropic funds Mestnorazdrajate funds Finalgon
This page is translated automatically with a help of Google Translate

Finalgon

See also oil Abbas

Roman name

Finalgon

The composition and the form of

1 g cream contains noniwamida 0.0017 g nikoboksila 0.0108 g

Of drugs

Ointment containing 0.4% vanililnonamida and 2.5% butoxiatilovy ester of nicotinic acid. Both substances are long expansion capillaries (small vessels) and hyperemia (redness) skin. The damage to skin is distracting, analgesic, противовоспалительно е Effects.

Pharmacokinetics

The farmakokinetike Finalgon drug is not available.

Pregnancy and lactation

Data on the use of drugs in pregnancy and lactation is not provided.

Contraindications

The cause ointment on the damaged skin and mucous membranes.

Side-Effects

Can individual intolerance preparation.

Patient interaction

Prescribed drug interaction Finalgon not described.

Overdosing

The cases drug overdose Finalgon not described.

The registration

005,357 (Ann.2001)

Indications for use

Muscle and joint aches different origins, tendowaginita (inflammation of tendons), adult (pristupoobraznaya intense pain in the lumbar region), neuritis (nerve inflammation), ishialgii (pain in the course of the sciatic nerve), sports injury.

Dosing and Administration

Local applied -nanosat on the skin. First, on the first application, squeezing the applicator (plastic tube) is not greater than 0.5 cm ointments. It is enough to damage the surface diameter of approximately 5-7 See Through applikatora ointment thoroughly scrub the skin in the affected area and cover his woollen cloth. The materials developed in a few minutes, the maximum effect seen in 20-30 min. The application of repeated response to the ointment may be decreased, which requires increasing dose. In all cases, the dosage should be tailored individually.

Form of

Ointment in the aluminium tubes in 1930 and 1950

Storage conditions

In a dry, cool place.

All products of this group